Back to User profile » Dr Katja Weisel
Papers published by Dr Katja Weisel:
Review
The Role of CELMoD Agents in Multiple Myeloma
van de Donk NW, Bahlis NJ, Pawlyn C, Gay F, Mateos MV, Weisel K, Lonial S, Richardson PG
OncoTargets and Therapy 2025, 18:921-933
Published Date: 27 August 2025
Original Research
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2017, 9:133-145
Published Date: 8 November 2017
Review
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
Weisel K
OncoTargets and Therapy 2016, 9:6037-6048
Published Date: 5 October 2016